The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Institute for Continuing Healthcare Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
It is the policy of the Institute to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All persons in control of content must disclose any significant financial interest or other relationships that may affect the content of this activity.
Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.
Ruben A. Mesa, MD
Professor of Medicine
Dr. Mesa has disclosed the following relevant financial relationships that have occurred within the past 12 months: Novartis/C; Gilead, Genentech, Incyte, Lily, NS Pharma, Pfizer/G.
Vikas Gupta, MD, FRCP, FRCPath
Associate Professor, Department of Medicine
Staff Physician, Leukemia/BMT Programs
The Princess Margaret Cancer Centre
Dr. Gupta has disclosed the following relevant financial relationships that have occurred within the past 12 months: Incyte, Novartis/A, G; Novartis/C, SB.
Brady L. Stein, MD, MHS
Assistant Professor, Medicine
Hematology Oncology Division
Feinberg School of Medicine
Dr. Stein has disclosed the following relevant financial relationships that have occurred within the past 12 months: Incyte/A, SB; Roche/H.